Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Amortization of Deferred Charges (2023 - 2025)

Historic Amortization of Deferred Charges for BrightSpring Health Services (BTSG) over the last 3 years, with Q3 2025 value amounting to $2.8 million.

  • BrightSpring Health Services' Amortization of Deferred Charges rose 1185.04% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 2507.82%. This contributed to the annual value of $12.1 million for FY2024, which is 4211.13% down from last year.
  • Per BrightSpring Health Services' latest filing, its Amortization of Deferred Charges stood at $2.8 million for Q3 2025, which was up 1185.04% from $2.8 million recorded in Q2 2025.
  • BrightSpring Health Services' Amortization of Deferred Charges' 5-year high stood at $5.3 million during Q2 2023, with a 5-year trough of $2.5 million in Q2 2024.
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $2.8 million (2025), whereas its average is $3.8 million.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first plummeted by 5312.5% in 2024, then skyrocketed by 1220.88% in 2025.
  • BrightSpring Health Services' Amortization of Deferred Charges (Quarter) stood at $5.2 million in 2023, then plummeted by 49.65% to $2.6 million in 2024, then grew by 7.98% to $2.8 million in 2025.
  • Its Amortization of Deferred Charges was $2.8 million in Q3 2025, compared to $2.8 million in Q2 2025 and $2.7 million in Q1 2025.